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Abstract 
Background: 
Both CAKUT and UTI can independently cause renal insufficiency with ultimate progression to 
ESRD, and CAKUT is a well-documented risk factor for UTI in children.  
Aim: 
To describe CAKUT in a cohort of children, between 2 weeks and 18 years of age, and to 
document the patterns of UTI in this group. 
Method: 
A retrospective medical record review was performed on all patients with documented CAKUT 
managed between January 2005 and December 2014. 
Results: 
The prevalence of CAKUT was 20% and the male: female ratio was 4.4:1. The median age at 
presentation was 8.4 months and the median duration of follow up was 39 months. At 
presentation 57% were under the age of one year and 21% were above the age of 5 years. PUV 
was the commonest type of CAKUT and a very low rate of VUR was noted.  
The incidence of UTI was 41.8% and the odds of getting a UTI were significantly increased 
among children with bladder anomalies, PUV and collecting system anomalies. Escherichia coli 
and Klebsiella pneumonia were the commonest bacteria isolated and, although more than 90% of 
both E. coli and Klebsiella pneumoniae were sensitive to amikacin, meropenem, imipenem and 
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ertapenem, more than 40% were resistant to commonly used oral antibiotics such as 
amoxicillin/clavulanate and trimethoprim-sulphamethoxazole. 
Prophylactic antibiotic use was highest among patients with PUV (35%) and, overall, patients 
who were not on a prophylactic antibiotic were five times more likely to have a UTI. The 
association between antibiotic prophylaxis and the development of antibiotic resistance could not 
be explored but there was a statistically significant association between the type of bacteria 
isolated and the use of antibiotic prophylaxis. 
Conclusion: 
Delayed presentation, the high rate of UTI and the high rate of antibiotic resistance to many first 
line oral antibiotics are all of concern. The study highlights the effectiveness of antibiotic 
prophylaxis in this group. Future research topics include determining the long term outcome, and 
the long term effects of antibiotic prophylaxis on renal function, in our cohort. 
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1. Introduction 
Urinary tract infection (UTI) is defined as the presence of micro-organisms in the urinary tract, 
with clinical signs and symptoms.
1
 Boys are more affected than girls in infancy, with a tenfold 
increased risk for uncircumcised compared to circumcised boys.
1
 However, after the first year of 
life and all through childhood, UTI affects 1-2% of boys and 5-8% of girls.
1, 2 
UTI is uncommon 
in the first two weeks of life, with an incidence of only 2% even in neonates who are 
bacteraemic.
3 
Any pathogenic micro-organism can cause UTI, but bacteria are the aetiology in 
more than 90% of cases. Gram negative bacteria are the leading cause of UTI in children, with 
Escherichia coli (E. coli) alone accounting for 75-90% of childhood UTIs worldwide.
1-5 
Other 
common causative organisms include Pseudomonas aeruginosa, Klebsiella pneumoniae, Proteus 
mirabilis, Streptococcus agalactiae (Group B Streptococcus),  Streptococcus viridans, 
Enterobacter species and  Staphylococcus aureus amongst others.
1-5
 
 
1.1 The clinical features of UTI 
The anatomical location of the UTI, the age of the child and the severity of the infection all 
determine the symptoms and signs of the illness. 
Lower tract UTI refers to bladder infection (cystitis), while upper tract UTI includes 
pyelonephritis and perinephric or renal abscess.  
Neonates can present with fever, hypothermia, apnoeic spells, poor perfusion, abdominal 
distension, diarrhoea, vomiting, lethargy, irritability, and convulsions. Other common signs in 
this age group are poor weight gain, palpable kidneys, jaundice, acidosis and electrolyte 
imbalance.
5, 6
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Older infants may present with difficulties in feeding, failure to thrive, diarrhoea, fever, 
malodorous urine, weak urinary stream, dribbling, pallor, irritability, lethargy and suprapubic 
and abdominal tenderness. 
5, 6
 
Older children are more likely to present with frequency, dysuria, enuresis, hesitancy, malaise, 
fever, flank pain, nausea and vomiting.
5, 6
 
1.2 The diagnosis of UTI 
Culture of bacteria from a correctly collected urine specimen is the gold standard for the 
diagnosis of UTI.
1-3, 6
 Suitable specimens for urine culture may be collected by “clean catch” 
mid-stream urine (MSU), urethral catheter or via suprapubic aspiration.
1-3
 
UTI is clinically defined as the presence of significant bacteriuria with symptoms of illness. 
Significant bacteriuria is defined as the culture of one properly obtained, clean-voided, 
midstream urine specimen growing greater than 100,000 colony forming units (CFU) per 
milliliter (ml) of a single uropathogenic organism, a catheterized specimen growing greater than 
10,000
 
CFU per ml of a single uropathogenic organism; or a specimen obtained by suprapubic 
tap growing greater than 1,000 CFU per ml of a single uropathogenic organism.
6-9
 
1.3 The complications of UTI 
 UTI is often associated with significant morbidity, with some cases progressing to renal 
scarring, hypertension and renal insufficiency.
4, 5 
UTI may even result in complications such as 
septicaemia and death.
4, 5
 A 27 year follow-up study from Sweden showed that focal renal 
scarring due to pyelonephritis in a child carried a 23% risk for hypertension and a 10% risk for 
end stage renal disease.
10
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1.4 The management of UTI 
As soon as a clinical diagnosis of UTI is made, a correctly collected urine specimen should be 
timeously sent to a laboratory for microscopy, culture and sensitivity testing.
6
 Thereafter, 
empirical antibiotic treatment is started and the antibiotic choice reviewed after the culture and 
sensitivity results are available.
2, 6
 The choice of empiric antibiotic should be based on local 
antimicrobial sensitivity patterns.
1, 2, 5
 The prompt and adequate treatment of an episode of UTI is 
crucial in order to prevent complications and long term sequelae.
1, 5 
The duration and route of antibiotic therapy depends on the clinical severity of the infection, the 
age of the child, the location of the infection and the presence of underlying structural 
abnormalities
.1-5
 
Neonates with UTI should be treated with parenteral antibiotics for 7-10 days, and a combination 
of ampicillin or cephalosporin, along with aminoglycosides, is usually used.
2, 5 
Infants and older 
children with acute pyelonephritis require initial intravenous antibiotics and a combination of 
aminoglycosides and ampicillin (or a cephalosporin) can also be used.
5, 6, 11
 
Children with symptomatic lower urinary tract infections are treated with oral antibiotics for 
seven days. 
5-7
 
Asymptomatic bacteriuria is only treated if the child is younger than five years, has a structural 
urinary tract abnormality, or if symptomatic UTI develops.
5
 
A urine culture should be done 3-7 days after the completion of therapy to exclude a relapse.
1-5
 
It is standard practice to screen for congenital anomalies of the kidney and the urinary tract 
(CAKUT) in certain groups of children with UTI. These include children with a delayed or 
4 
 
unsatisfactory response to treatment of the first febrile UTI, the presence of an abdominal mass 
or abnormal voiding pattern, and the presence of causative organisms other than Escherichia 
coli.
 1, 2, 5
 
Clinical follow-up is important for children with recurrent UTI, CAKUT or renal scarring. Urine 
should be screened for UTI at subsequent episodes of febrile illness following the first febrile 
UTI in a young child.
6 
1.5 Congenital Anomalies of the Kidney and the Urinary Tract (CAKUT) 
CAKUT comprises a wide range of renal system structural and functional malformations that 
may occur at the level of the kidney (e.g. hypoplasia and dysplasia), collecting system (e.g. 
hydronephrosis and megaureter), bladder (e.g. ureterocoele, vesicoureteral reflux and 
vesicoureteral junction obstruction) or urethra (e.g. posterior urethral valves).
12
  
CAKUT results from faulty development of the renal system which may occur in isolation, 
confined to the kidney and urinary tract, or may manifest as part of a syndrome with additional 
congenital malformations found outside the kidney and urinary tract.
12
 CAKUT constitutes about 
20 to 30% of all anomalies identified in the pre-natal period, and its prevalence among the 
general paediatric population ranges between 3.5-43%.
13-17
 
1.6 The diagnosis of CAKUT 
With improved prenatal screening many cases of CAKUT are diagnosed by antenatal 
ultrasonography performed at 18-20 weeks of gestation.
18, 19
 The most common antenatal 
manifestations of CAKUT include variations in gross morphology of the kidney, ureter or 
bladder with, or without, oligohydramnios. Postnatal manifestations can be the presence of a 
5 
 
palpable abdominal mass or a single umbilical artery, feeding difficulties, decreased urinary 
output, deficient abdominal wall musculature and undescended testes in a male infant, or multi 
organ birth defects.
18 
Ultrasonography, contrast radiography (e.g. VCUG and IVU), cystoscopy 
and Tc99- MAG3 scanning are all used in the post natal investigation of antenatally detected 
renal tract abnormalities or CAKUT.
2 
Urinary tract infection in children is well recognized as a marker for CAKUT in the postnatal 
period, and most children with CAKUT which is not detected antenatally are only referred for 
investigation after a diagnosis of UTI is made.
16
 Other possible reasons for referral, especially in 
those without urinary tract symptoms, are detection of CAKUT as an incidental finding during a 
routine examination or while the child is undergoing investigation for an unrelated complaint. 
For this reason, the diagnosis of CAKUT is often missed in otherwise seemingly healthy children 
who come from areas where routine, high standard, antenatal screening policies are not in place. 
Unfortunately, such patients are at risk for presenting later with chronic kidney disease.
20 
1.7 The association of CAKUT and UTI 
Congenital anomalies of the kidney and urinary tract (CAKUT) are a well-documented risk 
factor for the development of UTI in children.
1-5 
CAKUT is thought to alter the natural free 
unidirectional flow of urine causing stasis and thereby enhancing the growth of pathogenic 
micro-organisms.
16, 19
  
The incidence of CAKUT among patients with UTI ranges from 25-55%.
16 
Ring and Zobel 
found CAKUT in 42% of infants with UTI, with obstructive uropathy and vesicoureteral reflux 
(VUR) accounting for 37% and 59% of all the anomalies respectively.
21
 Also, in that study 61% 
of infants with CAKUT had UTI.
21 
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In addition to predisposing patients to UTI, some forms of CAKUT may also predispose to renal 
scarring, calculus formation, hypertension and renal failure, even in the absence of recurrent 
UTI.
11, 12, 20, 22 
CAKUT is responsible for 34-59% of CKD and 30-50% of cases of end-stage 
renal disease (ESRD) in children.
13-15
  
1.8 The management of UTI in children with CAKUT 
The importance of prompt treatment of acute episodes of UTI in this cohort of patients cannot be 
over-emphasized.
23
 As mentioned previously, hospital admission and parenteral antibiotics may 
be required in certain circumstances such as cases of severe illness and suspected 
pyelonephritis.
2, 5
  
Prevention of UTI in this group of patients is advocated due to their increased risk of renal 
scarring, hypertension and end stage kidney failure. 
2, 24-26 
In addition to enhancing personal hygiene and prevention of constipation, some clinicians place a 
selected group of CAKUT patients onto continuous antibiotic prophylaxis. Indications for 
continuous antibiotic prophylaxis include children less than 5 years with VUR, or other structural 
anomalies, and those who have had three documented UTIs in one year.
2, 5, 24, 25
 
The use of antimicrobial prophylaxis in patients with CAKUT and recurrent UTI is still 
controversial.
 26-29
 Those opposing the use of prophylactic antibiotics voice the concern that this 
practice may breed resistant strains of pathogens, increase the risk of breakthrough infections, 
and encourage adverse drug reactions. They also argue that the effectiveness of antibiotic 
prophylaxis is questionable, and that many patients will need to be treated to benefit one child. 
Finally, they fear that any benefit from this practice may be interrupted by low adherence of 
patients to the prescribed medication.
26-29   
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All the aforementioned concerns are due to the fact that previous studies on the use of 
prophylactic antibiotics were rife with contradictory results and divergent conclusions. However, 
some well controlled and randomized studies, including the PREVENT and RIVUR trials, have 
documented some benefits of antibiotic prophylaxis use in select groups of patients.
24, 28, 30, 31
 
Although prophylactic antibiotics have been recommended for children with grades IV and V 
VUR and other significant urological anomalies, the current recommendation is to discourage 
prophylactic antibiotic use in children with recurrent UTI who do not have CAKUT. Rather, they 
should be treated promptly and adequately whenever they get UTI. 
6, 29
  
Both CAKUT and UTI can independently cause renal insufficiency with ultimate progression to 
ESRD.
4, 20, 26
 A large body of literature exists on UTI in children, including documenting the 
presence of CAKUT among patients with UTI.
1-5,  16, 17, 21
  Also, previous studies on CAKUT 
have dealt with its prevalence and pattern among general paediatric populations, antenatal 
diagnosis, reviews and outcomes, methods of diagnosis, and recently its genetic aetiology.
11-18,  
20-22
 
 Finally, the author is not aware of any literature on CAKUT and its relationship to UTI in South 
Africa.
 
We hope that this study on UTI and CAKUT will be useful in helping us to develop new 
recommendations and management guidelines aimed at preventing, or reducing, the rate of 
progression to ESRD in this group of children. In addition, the knowledge gained will also be 
useful in guiding subsequent antibiotic prescribing protocols.  
Finally, this review aims to expand the knowledge of these conditions, specifically with relation 
to our own unique South African paediatric population. 
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1.9 The aims and objectives of the study 
1.9.1 Aim 
The study aimed to describe CAKUT in a cohort of children who attended the Division of 
Paediatric Nephrology at Charlotte Maxeke Johannesburg Academic Hospital (CMJAH), and the 
study also aimed to document the patterns of UTI in this group of patients. 
1.9.2 Objectives 
(1) To determine the prevalence of CAKUT amongst children attending the renal clinic at 
CMJAH. 
(2) To describe the different types of CAKUT seen in the study population. 
(3) To determine the rate of UTI, the types of causative organisms and the antimicrobial 
sensitivity patterns seen in the study population. 
(4) To determine the association between prophylactic antibiotic use and the rate of UTI in the 
study population. 
(5) To determine the association between prophylactic antibiotic use and the causative 
organisms of UTI in the study population. 
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CHAPTER 2 
2. Materials and methods 
2.1 Ethics clearance  
The study was conducted in full conformance with the principles of the Declaration of Helsinki, 
Good Clinical Practice and within the laws and regulations of South Africa. The interests of the 
patients were safeguarded and their anonymity guaranteed.   
Permission was obtained from the Chief Executive Officer of CMJAH. 
Ethical approval for this study was obtained from the Human Research Ethics Committee and the 
Postgraduate Committee of the University of Witwatersrand before commencement of the study. 
Ethics Clearance number: M150709 (Appendix A) 
2.2 Study design and study population 
The study was a retrospective review of the medical records of all patients between 2 weeks and 
18 years of age with documented congenital anomalies of the kidney and urinary tract being 
managed by the Division of Paediatric Nephrology at CMJAH between January 2005 and 
December 2014.  
The following groups of patients were excluded from the study: 
1. Neonates less than 2 weeks of age. 
2. Patients with confirmed retroviral infection. 
3. Patients with Diabetes Mellitus. 
4. Solid organ transplant recipients. 
10 
 
5. Non-transplant patients on immunosuppressive therapy (e.g. those with SLE, nephrotic 
syndrome and patients requiring plasma exchange) 
2.3 Study procedure 
The details of all patients cared for by the Division of Paediatric Nephrology at CMJAH are 
recorded in hard copy patient files which are kept in a secure filing room, located inside the 
division.  
The total number of all the patients that attended the division between January 2005 and 
December 2014 was retrieved from the hospital statistical unit. Files of patients that met the 
selection criteria were retrieved, and information relevant to the study was extracted (see 
attached Data Capture Sheet, Appendix B).   
 2.3.1 Definition of terms 
1. UTI 
The presence of a UTI was defined as finding significant bacteriuria with symptoms and signs of 
infection in the patient as charted in the files.
6-9
 
Significant bacteriuria was defined as: 
A. The culture of one properly obtained, clean-voided, midstream urine specimen growing 
greater than 100,000 colony forming units (CFU) per milliliter (ml) of a single 
uropathogenic organism.
6-9
 
B. The culture of one properly obtained catheterized urine specimen growing greater than 
10,000 CFU per ml of a single uropathogenic organism.
6-9
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C.  The culture of a urine specimen obtained by suprapubic tap growing greater than 1,000 
CFU per ml of a single uropathogenic organism.
6-9
 
2. Contaminated urine specimen 
A contaminated urine specimen was defined as one manifesting any growth of two or more 
different organisms, or the growth of Enterococcus faecalis or coagulase negative 
Staphylococcus.
32,33
 
3. Classification of CAKUT 
CAKUT was classified into anomalies of the kidney, anomalies of the collecting system, 
anomalies of the bladder, and anomalies of the urethra as suggested by Song and Yosypiv.
12 
  
2.3.2. Microbiology of the UTIs 
Details on the microbiology of the UTIs of the study population and their complete sensitivity 
patterns was obtained by submission of an application to the Corporate Data Warehouse (CDW) 
of the National Health Laboratory Service (NHLS) requesting extraction of data from the 
Laboratory Information System (LIS) at the CMJAH NHLS laboratory. The application 
requested data on the organism type and the susceptibility patterns of the UTIs diagnosed in the 
patients of our cohort (see attached NHLS Approval and Form, Appendix C). 
2.3.3. Recording of patients’ information 
Each patient was allocated a study number. Patients’ names and hospital numbers were not 
written on the data base. Information was recorded on the study proforma (Appendix B) by the 
primary investigator and then de identified and keyed into a data base using a study number. 
12 
 
2.4 Data analysis 
After data collation and cleaning, analysis was done using the Stata 13 statistical package.
34
 Data 
analysis was performed by the primary investigator and the results were re-checked by a 
statistician. Frequency tables and percentages were generated for all the major variables of 
interest. Continuous variables were described using median and interquartile range. Categorical 
variables were presented as percentages, pie and bar charts and comparisons between such 
variables were done using the Pearson Chi Square test and the Fisher’s exact test where 
appropriate. Regression analysis was used to assess the relationship between the different 
CAKUT classes and UTI, and also to assess the relationship between antibiotic use and UTI. A 
confidence interval of 95% was used, and for all analyses a p-value < 0.05 was taken as 
statistically significant. 
2.5 Limitations of the study 
Being a retrospective case review, some data were incomplete.  
The presence of co morbid conditions, which may have predisposed to UTI independent of the 
presence of CAKUT, such as chronic constipation, primary bladder dyssynergia, spina bifida and 
cerebral palsy were not taken into account.  
Although the protocol of the Division of Paediatric Nephrology is that all children referred for an 
evaluation have an abdominal ultrasound performed, not all get a MAG 3 scan and so, it is 
possible that patients with minor grades of reflux may have been missed.  
It is also possible that some children who attended our clinic may inadvertently not have had an 
abdominal ultrasound performed, and that some of the routine abdominal ultrasounds preformed 
during the study period may, due to technical error, have missed cases of CAKUT. These factors 
might affect the true prevalence of CAKUT in this study.  
13 
 
Finally, patients such as those with Down’s syndrome and ano-rectal anomalies (managed by the 
paediatric surgical team), who may not have been referred to our clinic, were not traced and 
reviewed for this study due to logistical and time constraints. Exclusion of these children may 
also have affected the prevalence of CAKUT in this study.  
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3. Results 
3.1 The general characteristics and prevalence of CAKUT 
Over the study period 691 new patients were seen at the clinic and, of those, 138 were diagnosed 
with CAKUT. This gave a prevalence of 20% for CAKUT in children referred to the Division of 
Paediatric Nephrology of CMJAH over the study period. 
Four records were excluded from analysis because they were lost to follow up after their 
diagnosis was made (they visited the clinic only once).  
Of the remaining 134 patients there were 109 males and 25 females giving a male: female ratio 
of 4.4:1 (Table 3.1). The median age at presentation was 8.4 months (IQR 1.9 - 47.7) and the 
median duration of follow up was 39 months (IQR = 12.5-81.7). 
 
Table 3.1 The age at presentation and sex distribution of the study population 
Age 
(months) 
Males 
 
 Females 
 
 Total 
 
 
 % N % N % N 
< 12 56.0 61 60.0 15 56.7 76 
12-59 22.0 24 24.0 6 22.4 30 
60-120 19.3 21 0.0 0 15.7 21 
>120 2.8 3 16.0 4 5.2 7 
Total 100.0 109 100.0 25 100.0 134 
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 3.2 The types of CAKUT 
The different types of CAKUT were classified into anomalies of the kidney, anomalies of the 
collecting system, anomalies of the bladder, and anomalies of the urethra. Figure 3.1 shows the 
distribution of the different classes of CAKUT among the study population. Anomalies of the 
urethra were the most common, while anomalies of the bladder were the least common anomaly 
seen. 
 
 
 
Figure 3.1 A pie chart showing the frequency of the different classes of CAKUT among the 
study population  
 
53, 40% 
11, 8% 10, 7% 
60, 45% 
n = 134 
KIDNEY ANOMALIES COLLECTING SYSTEM ANOMALIES BLADDER ANOMALIES URETHRAL ANOMALIESD
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3.2.1 The subgroups of CAKUT in each class. 
A detailed breakdown of the different types of CAKUT found in the study population is shown 
in Table 3.2 below. 
Table 3.2 A detailed breakdown of the different types of CAKUT 
CAKUT CLASS PERCENTAGE 
(%) 
 
FREQUENCY 
KIDNEY ANOMALIES   
Horse shoe kidney 0.7 1 
Hypoplastic kidney 5.2 7 
Duplex kidney 6.0 8 
Single kidney 13.4 18 
Multicystic Dysplastic kidney  14.2 19 
COLLECTING SYSTEM ANOMALIES   
Pelviureteric junction obstruction 7.5 10 
Vesicoureteric junction obstruction 0.7 1 
BLADDER ANOMALIES   
Prune Belly Syndrome 3.0 4 
Vesicoureteric reflux 4.5 6 
URETHRAL ANOMALIES   
Posterior urethral valves 44.8 60 
TOTAL 100.0 134 
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3.2.2 The age at presentation and sex distribution among the different types of CAKUT 
 Fifty seven percent (76/134) of the patients with CAKUT were under the age of one year when 
they first presented to the clinic, and 21% (28/134) presented above the age of 5 years. There 
was a significant statistical association between the age at presentation and the different types of 
CAKUT (p=0.024). Figure 3.2 below summarizes the sex and age groups of the different types 
of CAKUT at presentation. 
 
 
Figure 3.2 The age at presentation and the sex distribution of the different types of CAKUT 
18 
 
 
3.3 UTI in the patients with CAKUT   
3.3.1 The incidence of UTI 
Fifty-six (41.8%) of the patients with CAKUT had a culture proven UTI. The distribution of UTI 
among the main classes of CAKUT is shown in Table 3.3 below. There was a statistically 
significant difference in the rate of UTI among the different types of CAKUT (p=0.002).  
Bladder anomalies had the highest rate of UTI followed by collecting system anomalies. 
Table 3.3 The different types of CAKUT and the presence of UTI 
 
PRESENCE OF UTI NO  
 
UTI  
CAKUT  
TYPE 
% n % n TOTAL 
 
Kidney  
22.6 12 
 
77.4 41 53 
 
Duplex 
25.0 2 
 
75.0 6 8 
Single 
16.7 3 
 
83.3 15 18 
MCDK 
31.6 6 
 
68.4 13 19 
Others 
12.5 1 
 
87.5 7 8 
         
Collecting 
system 
54.5 6 
 
45.5 5 11 
PUJ 
60.0 6 
 
40.0 4 10 
VUJ 
0.0 0 
 
100.0 1 1 
      
Bladder 
70.0 7 
 
30.0 3 10 
PBS 
100.0 4 
 
0.0 0 4 
19 
 
VUR 
50.0 3 
 
50.0 3 6 
      
Urethra 
51.7 31 
 
48.3 29 60 
PUV 
51.7 31 
 
48.3 29 60 
      
Total 
41.8 56 
 
58.2 78 134 
                                                                                                                                                           p = 0.002 
 
To further assess the relationship between CAKUT types and UTI, a logistic regression model 
was employed as shown in Table 3.4 below. When compared with the group with kidney 
anomalies the odds of getting a UTI were increased approximately 9 fold among children with 
bladder anomalies, followed by those with urethral anomalies and then collecting system 
anomalies.  
Table 3.4 The logistic regression model for UTI occurrence in the different CAKUT types 
                 UTI  
EXPOSURE OR (95% CI)  P Value 
Kidney anomalies 1  
Bladder anomalies 9.3 (1.9600 -   44.1378)     0.005 
Collecting system anomalies 4.8 (1.1367 -   20.2983)     0.033 
Urethral anomalies  5.4 (2.0219 -  14.5381)     0.001 
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3.3.2 The causative organisms 
Two hundred and ninety-one (291) bacteria were isolated from 56 patients with 291 episodes of 
urinary tract infections. Escherichia coli was the commonest bacteria isolated, while 
Acinetobacter baumanni was the least common of the top five bacteria isolated. (Figure 3.3)  
                                                                  
 
Figure 3.3 Pie chart showing the different causative bacteria  
3.3.3 The antibiotic sensitivity patterns 
For each bacterium isolated in this study, the antibiotic used for the sensitivity testing was 
reported as either ‘sensitive’, ‘resistant’ or ‘not tested’. Table 3.5 below reflects the cases where 
110 (38%) 
72 (25%) 
29 (10%) 
20 (7%) 
18 (6%) 
42 (14%) 
E.coli Klebsiella Pn Pseudomonas aeruginos
Enterobacter spp Acinetobacter baumanni Others
n = 291 
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the antibiotics were tested and reported as sensitive.  More than 90% of both E. coli and 
Klebsiella pneumoniae were sensitive to amikacin, meropenem, imipenem and ertapenem. 
 
More than 40% of E. coli and Klebsiella pneumoniae were resistant to amoxicillin/clavulanate 
and trimethoprim-sulphamethoxazole. 
 
3.3.4 The causative organisms and the different types of CAKUT 
3.3.4.1 The distribution of the causative organisms among the different types of CAKUT 
Table 3.6 shows that PUV had the highest number of episodes of UTI (162) followed by MCDK 
and PBS respectively. E. coli was the most common causative organism in most of the CAKUT 
patients with the exception of MCDK, duplex kidney and hypoplastic kidney. There was a 
statistically significant association between the different CAKUT types and the bacteria isolated. 
(p <0.001) 
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 Table 3.5 The antibiotic sensitivity patterns of the bacterial isolates                   
                                                           The major causative bacteria  
Antibiotics E.C E.C 
 
Kle 
 
Kle Pseu 
 
Pseu 
 
Ente 
 
Ente 
 
Aci 
 
Aci 
 
Oth Oth 
 % n= 
110 
% n= 
72 
% n= 
29 
% n= 
20 
% n= 
18 
% n= 
42 
Amikacin 99.1 110 97.2 72 93.1 29 95.0 19 44.4 18 97.6 41 
Meropenem 99.1 109 98.6 72 93.1 29 90.0 19 50.0 17 88.1 38 
Imipenem 93.6 104 98.6 71 93.1 28 85.0 18 27.8 16 90.5 38 
Colistin 89.1 98 90.3 67 86.2 26 90.0 18 77.8 14 47.6 31 
Ertepenem 90.9 100 91.7 67 41.4 12 85.0 19 16.7 4 69.0 30 
Gentamicin 78.2 105 41.7 72 93.1 29 75.0 19 16.7 16 57.1 29 
Ciprofloxacin 65.6 106 41.7 72 89.7 28 80.0 20 16.7 18 71.4 38 
Cefoxitin 75.5 94 80.6 67 31.0 10 15.0 18 16.7 5 40.5 26 
Ceftazidime 70.9 106 38.9 71 79.3 29 55.0  38.9 18 45.2 28 
Cefixime 66.4 97 48.6 70 82.8 27 45.0 18 16.7 17 52.4 26 
Nitrofurantoin 85.5 102 52.8 65 0.0 3 35.0 20 0.0 7 9.5 19 
Ceftriazone 66.4 102 37.5 71 6.9 7 40.0 18 16.7 6 50.0 28 
Cefotaxime 66.4 102 37.5 71 6.9 7 40.0 18 16.7 6 50.0 28 
Cefuroxime 60.0 107 34.7 69 0.0 15 10.0 18 0.0 8 23.8 28 
Amoxicillin/ 
clavulanate 
47.3 105 27.8 71 0.0 7 5.0 19 0.0 3 23.8 17 
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Cephalexin 36.4 89 16.7 63 0.0 7 0.0 17 0.0 3 9.5 22 
TMP/SMX 15.5 106 31.9 70 6.9 27 55.0 19 11.1 18 40.5 33 
E. C = Escherichia coli, Kle = Klebsiella pneumoniae, Pseu = Pseudomonas aeruginosa, Ente= 
Enterobacter species, Aci = Acinetobacter baumanni, Oth = Others 
Table 3.6 The distribution of the bacterial isolates among the different types of CAKUT  
    BACTERIA    
CAKUT E.coli 
% 
Klebs 
% 
Pseudo 
% 
Enterobacter 
% 
Acineto 
% 
Others 
% 
Total 
n 
KIDNEY ANOMALIES 
DK 22.2 0.0 27.8 5.6 22.3 22.2 18 
MCDK 34.4 37.5 0.0 9.4 12.5 6.3 32 
Hypoplastic 0.0 0.0 100.0 0.0 0.0 0.0 2 
SK 55.0 25.0 15.0 0.0 5.0 0.0 20 
COLLECTING SYSTEM ANOMALIES 
PUJ 62.5 18.8 6.3 6.3 0.0 6.3 16 
VUR 58.8 11.8 0.0 17.6 0.0 11.8 17 
BLADDER ANOMALIES 
PBS 33.3 16.7 4.2 4.2 8.3 33.3 24 
PUV 34.6 28.4 10.5 6.8 4.3 15.4 162 
TOTAL 37.8 24.7 10.0 6.9 6.2 14.4 291 
                                                                                                                                   p<0.001 
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3.4 The use of prophylactic antibiotics and their relationship to UTI 
Out of the 134 patients with CAKUT, 36 patients had been started on prophylactic antibiotics 
after the diagnosis of CAKUT was made. Figure 3.4 below shows the types of CAKUT on 
prophylactic antibiotics. The frequency of prophylactic antibiotic usage was highest among 
patients with PUV (35%). 
 
 
Figure 3.4. The pattern of antibiotic prophylactic use amongst the different types of 
CAKUT 
 
Ninety-eight (98) patients were not commenced on any prophylactic antibiotic. Forty-nine (50%) 
of those who were not given prophylactic antibiotics had at least one episode of UTI on follow 
up, while only seven (19.4%) of those on antibiotic prophylaxis developed a UTI. The 
association between UTI and prophylactic antibiotic use is shown in Table 3.7 below. There was 
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a statistically significant association between the use of prophylactic antibiotics and the rate of 
UTI (p < 0.001). Patients who were not on a prophylactic antibiotic were five times more likely 
to have a UTI than those who were on a prophylactic antibiotic (OR = 5.21, P = 0.001, 95% CI: 
1.9906 – 13.6277). 
 
 
Table 3.7 The association between antibiotic prophylactic use and UTI  
   UTI  
  YES 
n (%) 
NO 
n (%) 
TOTAL 
n (%) 
ANTIBIOTIC YES 7 (19.4) 29 (80.6) 36(100.0) 
PROPHYLAXIS NO 49 (50.0) 49 (50.0) 98 (100.0) 
 TOTAL 56 (41.8) 78 (58.2) 134 (100.0) 
p<0.001 
A more detailed breakdown of the use of prophylactic antibiotic and the rate of UTI among the 
different classes and sub groups of CAKUT can be seen in Table 3.8. There was a decreased 
frequency of UTI in patients on antibiotic prophylaxis in all the different classes and sub groups 
of CAKUT.  
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Table 3.8. A breakdown of the CAKUT subgroups, the use of antibiotic prophylaxis and 
the rate of UTI. 
  
 
 UTI          
  
 CAKUT   
On Prophylaxis 
  No 
Prophylaxis 
 Total 
 % n  % n n 
Kidney 18.2 
11  23.8 42 53 
Duplex  0.0 
0  25.0 8 8 
Single  40.0 
5  7.7 13 18 
MCDK  0.0 
5  42.9 14 19 
Others  0.0 
1  14.3 7 8 
   
     
Collecting system  0.0 
2  66.7 9 11 
PUJ  0.0 
2  75.0 8 10 
VUJ  
0.0 0  0.0 1 1 
   
     
Bladder  0.0 
2  87.5 8 10 
PBS  
0.0 0  100.0 4 4 
VUR  0.0 
2  75.0 4 6 
   
     
Urethra  23.8 
21  66.7 39 60 
PUV  23.8 
21  66.7 39 60 
   
     
Total 19.4 
36  50.0 98 134 
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3.4.1. The association between prophylactic antibiotic use and the bacteria isolated  
Table 3.9 shows the effect of prophylactic antibiotics on the pattern of the bacteria isolated 
among the different types of CAKUT. Patients who were on prophylactic antibiotics showed an 
altered pattern of bacteria isolated, with Klebsiella pneumoniae being the most common 
organism isolated, rather than E coli, when compared to the group that were not on prophylactic 
antibiotics. There was a statistically significant association between the type of bacteria isolated 
and the use of antibiotic prophylaxis (p= 0.031).  
 
Table 3.9. The association between prophylactic antibiotic use and the bacteria isolated 
from the different types of CAKUT. 
  Antibiotic prophylaxis  
Bacteria  YES 
 
 NO 
 
 
 % n % n 
E. Coli 25.0 13 41.0 97 
Klebs 36.0 19 22.0 53 
Pseudo 13.0 7 9.0 22 
Entero 11.0 6            6.0 14 
Acineto 2.0 1 7.0 17 
Others 13.0 7 15.0 35 
TOTAL 100.0 53 100.0 238 
p= 0.031 
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4. DISCUSSION 
4.1 Underestimation of the prevalence of CAKUT 
CAKUT constitutes about 20 to 30% of all anomalies identified in the pre-natal period
13-15
 and 
its reported prevalence among the general paediatric population ranges between 3.5 and 43%.
16,17
 
The prevalence of CAKUT in this study (20%) falls within the range of results (3.5 – 43%) 
reported from other studies around the world. 
16-18,35,36 
The study which reported a prevalence 
rate of 43% was from a unit in Iraq. This study was a case control study in a general paediatric 
setting where 128 children (64 with UTI, and 64 without UTI) were screened for CAKUT using 
abdominal ultrasound.
16
 Other studies obtained their study populations from the general 
paediatric setting, including urology clinics, and prospectively screened all children who 
presented to hospital for CAKUT, and not only those with UTIs or renal pathologies.
16-18,35,36 
Although our study reflects the incidence of CAKUT in a select group of patients (i.e. those 
referred to a specialist paediatric nephrology clinic) in whom we could expect to find a higher 
incidence of CAKUT compared to the general paediatric population, there are a number of 
reasons that our results may nevertheless still underestimate the true prevalence of CAKUT in 
our population; 
 It is well recognized that some forms of CAKUT remain asymptomatic throughout life 
and may never be detected except through screening.
16,20,21 
Our clinic only sees children 
who have been referred for a nephrology evaluation and it is likely that many children in 
the general paediatric population which our unit serves may have asymptomatic CAKUT 
and so would not have been diagnosed and referred for investigation.  
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 Patients with CAKUT who were seen primarily at the urology or paediatric surgery 
clinics at our hospital may not have been referred to us for follow up, despite this being 
the protocol in place.  
 Some cases of CAKUT may not have had an ultrasound performed by our clinic, despite 
this being the protocol in place, and some of the routine abdominal ultrasounds that were 
performed during the study period may have missed some cases of CAKUT due to 
technical error 
 In our study 159 different anomalies were documented for the 134 patients. However, as 
part of our study protocol we labeled any patient with two or more types of CAKUT as 
having only one type of CAKUT. This was based on the methodology used in a study 
reported from Egypt.
37 We chose the ‘primary’ CAKUT and ignored the extra anomaly 
which was assumed to have developed secondary to the ‘primary’ CAKUT. 
 
4.2 The types of CAKUT  
PUV was the commonest type of CAKUT in this study. Most reports estimate the incidence of 
PUV to be in the range of 1:5000 to 1:8000 live births. However, estimates have varied as widely 
as 1:2000 and 1:25000 live births. 
38
 In a study from Australia, a live-birth incidence of 1.28 per 
10,000 was reported. In that study, 53% of cases were suspected on antenatal ultrasound and of 
the remaining cases, 45% were detected in the neonatal period, with 50% of all postnatal cases 
presenting with urinary tract infection. 
38 
The prevalence of PUV in our study was close to 45%. This is in keeping with the findings from 
the study from Egypt where PUV was the commonest (36.4%) among the 107 different types of 
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CAKUT reviewed by Soliman et al.
37 
In contrast, two other studies showed “kidney anomalies” 
as being the leading type of CAKUT
20,39
, and a study from Iraq documented ”bladder anomalies” 
as the most common CAKUT.
16
  
Differences in the classification of CAKUT, methodology and study design make it difficult to 
compare our study results with those of other studies. While Gupta et al used both children and 
adults as their study population, Bondagi reviewed only antenatally diagnosed CAKUT within a 
perinatal population.
 20,39
  
 The reason for the high prevalence of PUV in our study could be due to their tendency to 
present early with symptoms of obstructive uropathy and UTI, whereas patients with other forms 
of CAKUT, e.g duplex collecting system, are often asymptomatic and so may not be referred for 
investigation.
20 
Previous review articles on VUR suggest the general occurrence of VUR in healthy children to 
be 1-2%.
40,41
 However, primary studies report a frequency of 0-30%.
42
 Studies from developed 
countries have found high rates of VUR in the general paediatric population.
42,43
 A study from 
Finland reported a prevalent rate of 35% among 406 children with UTI while a Canadian study 
found a rate of 17.2% and 31% in a general paediatric population with normal kidneys and in 
children with UTI respectively.
42,43
 This is in contrast with much lower prevalence rates for VUR 
previously documented in black South African children.
44,45
 
The prevalence of primary VUR in our study was 4.5%. This is in keeping with the 2 previous 
studies from South Africa.
 44,45
 We postulate that reasons for the much lower rates in black 
African children are most likely due to genetic factors.
46
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4.3 The age at presentation and the sex distribution of CAKUT 
Males were more likely to develop CAKUT than females which is in keeping with previous 
studies from the developing world.
21, 37,39, 47-50  
The male:female ratio in our study was 4.4:1 and 
sex was significantly associated with development of CAKUT (P<001). This highlights the need 
to have a high index of suspicion for CAKUT in every male child who presents with urinary 
symptoms. 
The median age at presentation in our study was 8.4 months (IQR 1.9 - 47.7). This is of real 
concern as it reflects late presentation of many patients with CAKUT for investigation. Ideally, 
significant congenital anomalies should be diagnosed during the prenatal period and then 
followed up postnatally.  
In our setting, a combination of poor rates of routine antenatal screening, and also late booking 
for antenatal care, results in few cases being referred as a result of detection by antenatal 
anomaly screening programs. In addition in some cases, even when a diagnosis had been made 
antenatally, parents still did not bring their children to hospital until they develop symptoms. In 
some extreme cases, some mothers delayed coming to the nephrology clinic even after being 
referred from the general paediatric clinics This underscores the need for proper counseling of 
the parents by the referring doctor about their child’s illness.  
4.4 UTI in CAKUT 
4.4.1 The incidence of UTI in patients with CAKUT 
UTI remains an important pointer to CAKUT in children.
16,19,21
 Every child with CAKUT should 
be screened for UTI and vice versa and, since both CAKUT and UTI can independently cause 
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renal insufficiency with ultimate progression to ESRD, the need to minimize or prevent their co-
existence cannot be over-emphasized.
4,20,26
 
There is a paucity of data on the prevalence of UTI among patients with CAKUT. Previous 
studies have generally focused on the prevalence of CAKUT among children with UTI which 
ranges between 25 – 59 %.16,17,21,51  
The prevalence of UTI in our study was 41.8%. This is lower than the 61% found among infants 
with CAKUT in Austria.
21
 Regardless of the differences in the study population and 
methodology employed in both studies, it is clear that the prevalence of UTI in patients with 
CAKUT is high.  
4.4.2 The CAKUT types with the highest rates of UTI   
The differences in the rates of UTI among the different CAKUT types reached statistical 
significance (p = 0.002).  Bladder anomalies as a group were the CAKUT type with the highest 
rate for UTI followed by PUV and collecting system anomalies respectively. When compared to 
kidney anomalies, the likelihood of getting a UTI was increased approximately nine fold among 
children with bladder anomalies and fivefold among those with PUV and collecting system 
anomalies.  
We are not aware of any previously published work specifically looking at which type of 
CAKUT is associated with the highest rate for UTI, using our classification, but severe grades of 
VUR have been shown to be associated with recurrent UTI and subsequent scarring and PBS has 
also been associated with increased rates of UTI.
24,29-31,52,53 
Posterior urethral valves also been 
shown to exhibit a high rate for UTI as reflected in the study by Bomalaski et al.
54 
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All these study findings reinforce the fact that many types of CAKUT have a significant 
tendency to predispose to UTI. A diagnosis of collecting system and bladder anomalies, or PUV, 
should raise the suspicion of UTI in the index patient.  
4.5 The causative organisms for UTI in patients with CAKUT  
Studies done on UTI have shown that E.coli is the commonest causative organism in children 
with and without CAKUT.
 1-5, 55-59
 In our study, overall, E. coli was the commonest isolated 
bacteria, followed by Klebsiella pneumoniae, and Pseudomonas aeruginosa respectively.  This 
finding is in keeping with other studies on CAKUT which also identified E coli as the 
predominant organism isolated.
16,17,60 
 As in our study, a report from London also found that 
Klebsiella pneumoniae and Pseudomonas aeruginosa respectively were the next most common 
bacteria causing UTI in children with CAKUT after E.coli.
60
 In contrast however, Alkhateeb et 
al from Iraq documented Proteus mirabilis as their second most frequent bacteria, before 
Klebsiella pneumoniae.
16
  
E. coli was the most common causative organism in most of the CAKUT patients with the 
exception of MCDK, duplex kidney and hypoplastic kidney, and, although previous studies did 
not evaluate the relationships between different types of CAKUT and types of causative 
organism isolated, 
16,17,37,60
 we found that there was statistically significant association between 
the different CAKUT types and the bacteria isolated (p<0.001). 
Our findings support recommendations that the isolation of organisms other than E Coli should 
be an indication for ultrasound screening for CAKUT during acute infections.
61 
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4.6 The antimicrobial sensitivity patterns of the isolated bacteria  
Ceftriaxone, ceftazidime, cefotaxime, gentamicin and amikacin are among the highly 
recommended parenteral antibiotics for the treatment of childhood UTI, and  recommended oral 
antibiotics for UTI treatment in children include amoxicillin/clavulanate, cefixime, cefuroxime, 
cefpodoxime and cephalexin.
6,7,58
 Previous studies on antimicrobial sensitivity patterns have 
been done on the general paediatric population although not on children with CAKUT per se, 
and many older studies did not include antibiotics such the carbapenem group.
55-59,62
  
When reviewing our data on antimicrobial sensitivity patterns of the isolated bacteria, it must be 
kept in mind that, in our study, 41.8% of the children were on prophylactic antibiotics and 
children on prophylactic antibiotics are often infected with organisms that are resistant to 
commonly used antimicrobials.
28,59,65,66 
 
A study from Wisconsin showed that CAKUT was associated with a higher frequency of drug-
resistant uropathogen infections.
66 
The study also showed a high rate of resistance to 3
rd
 
generation cephalosporins in children receiving antibiotic prophylaxis.
66 
 
The extent to which antibiotic prophylaxis influenced the development of microbial resistance in 
this study was not explored. Unfortunately, due to technical limitations in the reporting of 
information requested from the Corporate Data Warehouse (CDW) of the National Health 
Laboratory Service (NHLS), we could not analyze the effect of antibiotic prophylaxis on 
antibiotic sensitivity patterns other than to compare the group who had been on prophylaxis with 
the group who had not (see 4.7 and 4.8 below).  
In our study, the antimicrobial sensitivity patterns of the isolated bacteria were tested using 17 
different antibiotics. Antibiotics to which the majority of the bacteria isolated were sensitive to 
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were meropenem (100%), colistin (100.0%), ertapenem (100.0%), amikacin (99.1%), imipenem 
(99.0%), gentamicin (81.9%), and ciprofloxacin (67.9%). More than 90% of both E. coli and 
Klebsiella pneumonia were sensitive to colistin, meropenem, ertapenem, imipenem and 
amikacin. However, because of their cost, and risk of abuse with subsequent microbial 
resistance, the carbapenems should not be used as first line drugs in the treatment of childhood 
UTI.  
E. coli also demonstrated high levels of sensitivity to antibiotics like gentamicin, ciprofloxacin, 
cefixime ceftazidime, ceftriaxone and nitrofurantoin in this study. This finding agrees with 
previous studies.
55-58 
Antimicrobial resistance varies across regions and is influenced by different local antibiotic 
practices, but all agree that antibiotic resistance is on the increase worldwide.
58,64
 In our study 
more than 40% of E. coli and Klebsiella pneumoniae were resistant to both trimethoprim-
sulphamethoxazole, amoxicillin/clavulanate  and cephalexin. In addition, thirty seven percent of 
E. coli and 61% of Klebsiella pneumonia showed resistance to cefuroxime.  
 Antimicrobial resistance to trimethoprim-sulphamethoxazole by bacteria that cause UTI is 
widely documented in literature.
55-59,62
 The increased rate of resistance to trimethoprim-
sulphamethoxazole is thought to be due to its widespread use as a prophylactic antibiotic for UTI 
and Pneumocystis jirovici  infections in HIV positive patients,
55-59,62
 and in areas with high levels 
of resistance to trimethoprim-sulphamethoxazole, the drug should no longer be used as the first 
line of treatment of UTI.
55-59,62
 The findings of our study highlight that this also applies to our 
cohort of patients.  
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Studies from Khartoum, Ethiopia and Nigeria have also reported that organisms which cause 
UTI show high levels of resistance to amoxicillin and amoxicillin/clavulanate.
55-57,62   
Thirty-seven percent of E. coli and 61% of Klebsiella pneumonia showed resistance to 
cefuroxime in this study. This can be compared to the findings from Turkey where 38% of E.coli 
and 25% of Klebsiella pneumonia showed resistance to cefuroxime.
 67
   
E. coli showed 44.5% resistance to cephalexin in our study. A previous study reported 
cephalexin as one of the three antibiotics to which E. coli is most resistant.
57
 However, they 
documented a lower rate (26.5%) of resistance to Cephalexin when compared to our current 
study.
58  
We are concerned that although recommended oral antibiotics for UTI treatment in children 
include amoxicillin/clavulanate, cefuroxime and cephalexin, our data show high levels of 
bacterial resistance to these antibiotics.
6,7,58
 Our policy has been that CAKUT patients presenting 
with their first UTI are treated empirically according to the above guidelines and then our 
treatment of subsequent UTIs is based on the individual patient’s prior urine culture results. Re-
adjustment in the choice of empirical antibiotics is made once the antimicrobial sensitivity result 
of the index UTI is available in keeping with recommendations reported elsewhere.
6
 
 
4.7 The association between antibiotic prophylaxis and UTI patterns 
Preventing recurrent UTIs in patients with CAKUT is one of the most effective ways of 
preventing progression to end stage kidney disease in this cohort of children
2,24-26
 but, due to 
conflicting reports on the benefits of antibiotic prophylaxis in preventing UTI, the use of 
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prophylactic antibiotics to prevent recurrent UTI/renal damage in children is still 
controversial.
6,7,29,63
  
Brandstrom et al agreed that antibiotic prophylaxis can protect against recurrent UTI and long-
term sequelae in selected groups of patients
28 
and other recent studies also advocate the use of 
prophylactic antibiotics to prevent recurrent UTI in infants with moderate to severe congenital 
hydronephrosis.
25,27
  
Simoese et al suggested a subgroup of patients that might benefit from antibiotic prophylaxis. 
These include those with obstructive uropathy until surgical intervention is achieved, the 
presence of severely dilated urinary tract, and grades III-V vesicoureteral reflux.
63 
Craig et al in Australia showed that low dose antibiotic prophylaxis decreased subsequent UTI 
episodes in children who had a previous UTI, and recent well designed controlled trials have 
shown that some subgroups of children do benefit from antibiotic prophylaxis.
24,25,28,30,31,68 
In our study population, the episodes of UTI were significantly decreased among our patients on 
antibiotic prophylaxis. Thirty-six (26.9%) of the 134 patients with CAKUT were started on 
prophylactic antibiotics after the diagnosis of CAKUT was made and ninety-eight (73.1%) were 
not commenced on any antibiotic. Over a follow up period of 39 months (IQR = 12.5-81.7), 7 
(19.4%) of those on prophylactic antibiotics developed at least one UTI as compared to 49 
(50.0%) of those who were not on prophylaxis (p = 0.001). The odds for developing a UTI were 
increased 5 fold among patients with CAKUT who were not on prophylactic antibiotics (OR = 
5.21, p = 0.001, 95% CI: 1.9906 – 13.6277) 
Craig’s study found that 55 (19%) of 288 children without antibiotic prophylaxis developed UTI, 
while only 36 (13%) of the 288 in the antibiotic group developed UTI (Hazard ratio in antibiotic 
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group = 0.61; 95% CI: 0.40 - 0.93).
31 
Also, in the RIVUR trial, antibiotic prophylaxis with 
trimethoprim/sulfamethoxazole decreased the risk of UTI recurrence by 50% among 607 
children with VUR.
30
 
Our results emphasize the positive role that antibiotic prophylaxis can play in the prevention of 
UTI in children with CAKUT. Unfortunately, due to the retrospective nature of our data 
collection, we could not analyze the long term effect of antibiotic prophylaxis on renal function 
but we feel that just to be able to prevent the morbidity of each UTI, it is worthwhile putting at 
least some children with CAKUT, as suggested by Simoese, on antibiotic prophylaxis.  
Currently, the division of paediatric nephrology at CMJAH does not have any antibiotic 
prophylaxis protocol for the management of patients with UTI and/or CAKUT. Each index 
patient is treated based on his/her unique clinical condition. The results of this study will help us 
change this policy to place more patients onto antibiotic prophylaxis 
4.8. The association between prophylactic antibiotics use and the bacterial isolates from 
CAKUT patients with UTI 
 As mentioned above, the extent to which antibiotic prophylaxis influenced the development of 
microbial resistance in this study was not explored other than to compare the group who had 
been on prophylaxis with the group who had not (see 4.6 above).  
There was a statistically significant association between the type of bacteria isolated and the use 
of antibiotic prophylaxis (p= 0.031). In the group who were on antibiotic prophylaxis, Klebsiella  
pneumoniae was the most common organism isolated as opposed to E coli in the group that were 
not on prophylactic antibiotics.  
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Our study findings are in keeping with other reports which have showed that children on 
prophylactic antibiotics are often infected with causative organisms other than E. coli.
59,62,65,66 
It is recommended that the urine bacterial profile of CAKUT patients on prophylactic antibiotics 
be reviewed regularly.
28,61
 This will enable physicians to remain ahead of emerging strains of 
atypical organisms in this cohort of patients.
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5. CONCLUSION 
As this is the first review that we have performed on our cohort of patients with CAKUT we 
found our study results to be very enlightening. We are concerned at the delayed presentation of 
many of our cases of CAKUT, even in circumstances where an antenatal or post natal diagnosis 
had been made. This highlights the lack of antenatal screening in our facilities and also our poor 
patient counselling skills. 
PUV was the commonest type of CAKUT in our cohort of patients and, as opposed to reports 
from first world countries, VUR made up a very small part of our cohort. This emphasizes the 
importance of doing home grown research on our own populations rather than relying on reports 
of patient populations which may differ from our own. 
In light of the fact that UTI among patients with CAKUT predisposes to CKD, we are concerned 
with the high prevalence of UTI detected in our study (41.8%). Bladder anomalies and PUV 
were the types of CAKUT with the highest risk for UTI in our center, and doctors caring for 
children with these anomalies should maintain a high index of suspicion for a UTI whenever 
such cases are seen. 
Escherichia coli was the commonest cause of UTI in our group of patients with CAKUT.  Other 
common bacteria included Klebsiella pneumonia, Pseudomonas aeruginosa and Enterobacter 
Spp respectively. Meropenem, colistin, ertapenem, amikacin, imipenem, gentamycin and 
ciprofloxacin were the antibiotics that most of the organisms where sensitive to, and 
trimethoprim-sulphamethoxazole, cephalexin, amoxicillin/clavulanate and cefuroxime were the 
antibiotics which demonstrated the highest levels of bacterial resistance. This is of concern as 
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our current first line of treatment for cystitis is cephalexin or amoxicillin/clavulanate, and for 
pyelonephritis we use cefotaxime or ceftriaxone as our drugs of choice.  
Our results demonstrate that, in cases of CAKUT with a UTI which do not rapidly respond to 
empiric therapy, doctors should have a high index of suspicion that the causative organism may 
be resistant to the antibiotic selected for therapy, and should be prepared to rapidly adjust the 
antibiotic selection accordingly.   
Our results showed that antibiotic prophylaxis was very effective in decreasing the rate of UTI in 
our cohort of patients and, although we could not ascertain which particular subgroup of 
CAKUT would benefit most from prophylactic antibiotic use, we agree that it is worthwhile 
putting at least some children with CAKUT on antibiotic prophylaxis.  
5.1 Recommendations 
 A high index of suspicion for CAKUT should be entertained for all children with UTI, 
especially if they are boys, infants, or there is recurrence of UTI 
 Children with either suspected or confirmed CAKUT should be timeously referred to a 
paediatric nephrology service for correct management and long-term follow up 
 Routine, high quality, prenatal ultrasound examination for all pregnant women should be 
encouraged to increase the antenatal detection rate for CAKUT 
 Parents of children with CAKUT should be properly counselled with regards to follow up 
appointments and subsequent pregnancies 
 It is worthwhile to consider putting at least some children with CAKUT onto antibiotic 
prophylaxis. 
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 There should be rapid adjustment of antibiotic selection in patients with poor response to 
empirically prescribed antibiotics. 
 
 
5.2 Topics for future research 
The results of our study have led us to consider the following topics for future research: 
1. To determine the long-term outcome of the CAKUT patients under our care 
2. To determine which of the conditions which make up CAKUT are most suitable for 
antibiotic prophylaxis 
3. To determine which antibiotics are most suitable for prophylaxis in these conditions 
4. To determine the long term effects of antibiotic prophylaxis on renal function in children 
with CAKUT 
5. To study the long term effects of antibiotic prophylaxis on UTI resistance patterns in 
children with CAKUT. 
6. To study the prevalence of CAKUT in children with ano-rectal anomalies and other 
syndromes (e.g. Down’s syndrome) who may have renal abnormalities as part of the 
syndrome. 
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Appendix A: Ethics Approval Certificate 
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Appendix B: Data Collection Sheet: 
 
1. Study No.: 
 
2. Date of  1st presentation to  
the Renal Clinic, CMJAH. 
 
 
3. Sex                             
                                                
                                                                  
4. Age at presentation: 
 
5. Weight at 1st Visit (Kg)………………………….Z Score……………………. 
 
6. Height at 1st Visit (CM)………………………… Z Score…………………… 
 
 
7. Any diagnosis of CAKUT?      
      
D D M M Y Y 
      
Male  Female  
 Months 
YES  NO  
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8. If yes to Q 7, Any Prenatal diagnosis of CAKUT?          
 
       
9. Type of CAKUT:  
                                               
S/N TYPE      OF      CAKUT a.Yes b. No 
1 Single kidney a.Yes b. No 
2 Duplex kidney a.Yes b. No 
3 Pelvic kidney a.Yes b. No 
4 Horse-shoe kidney a.Yes b. No 
5 Hypoplastic kidney a.Yes b. No 
6 Dysplastic kidney a.Yes b. No 
7 Multicystic Dysplastic kidney  a.Yes b. No 
8 Hydronephrosis a.Yes b. No 
9 Pelvi-uretericjunction obstruction a.Yes b. No 
10 Duplex collecting system a.Yes b. No 
11 Ureterocoele a.Yes b. No 
12 Vesicoureteral reflux a.Yes b. No 
13 Vesicouretericjunction a.Yes b. No 
YES  NO  UNKNOWN  
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obstruction 
14 Megacystis a.Yes b. No 
15 Bladder extrophy a.Yes b. No 
16 Posterior urethral valve a.Yes b. No 
17 Congenital urethral stenosis a.Yes b. No 
 
 
 
 
10. Serum Creatinine at 1st Visit (mmol/l)………………… 
 
 
 
11. GFR@ at First Visit (mls/min/1.73m2): 
 
 
 
 
12. Date of last visit: 
 
 
GFR ≥90   60 - 89 30 - 59 12 - 29 <15  
CKD 
STAGE 
1 2 3 4 5 
D D M M Y Y 
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13. Weight at last Visit (Kg)………………………..….Z Score…… 
14. Height at last Visit (CM)………………………….. Z Score…… 
15. Serum Creatinine at Last Visit (mmol/l)……………………….. 
 
16. GFR@ at last visit: 
 
 
       
 
17.  Any UTI? 
 
 
18.  If yes to Q 17, how many episodes of UTI? ................................ 
 
19.  If yes to Q 17, what was the age at 1st  UTI :              
 
 
20.  Details of U T I. 
 GFR ≥90   60 - 89 30 - 59 12 - 29 <15 
CKD 
STAGE 
1 2 3 4 5 
YES  NO  
 Months 
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UTI 
EPISODE 
ORGANISM  
ISOLATED 
SENSITIVE 
ANTIBIOTICS 
RESISTANT 
ANTIBIOTICS 
    
    
    
    
    
    
 
 
21.  Any prophylactic antibiotics? 
 
 
22.  If answer to Q21 is yes, when was the prophylactic antibiotic                 
                started?................(a) Before first UTI     (b) After first UTI 
 
 
 
 
YES  NO  
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Appendix C: Approval for data collection from NHLS information system 
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     NATIONAL HEALTH LABORATORY SERVICE HELPDESK 
Tel: (011) 386-6125/6/7/9 Fax: (011) 386-6308 email: helpdesk.1@nhls.ac.za 
APPLICATION FOR DATA FROM NHLS INFORMATION SYSTEMS (Q-Pulse FMI0069) 
Each application will be approved or rejected subject to the ability to extract this data and the 
availability of the data, and subject to the intended usage of the requested data. Applications that 
are incomplete and/or do not contain supporting documentation, will be rejected. 
 
APPLICANT’S DETAILS 
Applicant 
Name 
Nneka 
Chioma 
Okoronkwo 
Tel 
No 
(+27)741950826  Email 
      
nnekaceo@rocketmail.com 
Business Role / Designation 
Fellow – Paediatric Nephrology 
 
Laboratory / Department / Branch / 
Region (Internal applicants) 
Division of Paediatric Nephrology, CMJAH 
Organisation (External applicants) 
Department of Paediatrics, CMJAH 
 
Supervisor 
Name 
Cecil Levy 
Tel 
No 
(082)7712905 Email 
cecil.levy@wits.ac.za 
 
Supervisor 
Designation 
Head of the Division of Paediatric Nephrology, CMJAH 
CONDITIONS 
 Data / Information is not to be used in contravention of Sections 14, 15, 16 and 17 of 
the National Health Act 61 of 2004 and the Promotions of Access to information Act 2 
of 2000. 
 The applicant undertakes to ensure that the data supplied to it by the NHLS is used 
ethically and solely for the purposes for which it is provided as detailed in this 
application, and further acknowledges that it shall remain liable for any breaches of 
this clause by the end user. 
 If the purpose for the data requested in this application is research or if patient 
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identity linked data is required, ethics approval and a one page summary of the 
protocol shall be attached to this application form. It is the responsibility of the 
applicant to ensure that their institutions’ Human Ethics approval includes explicit 
authorisation to access the requested NHLS data. 
 The applicant undertakes to store the NHLS data in a confidential manner by 
separating patient identifying details from laboratory data and storing the master list 
that links patient identifying details to study patient identifiers in a separate, secure 
location. 
 The information is for the private use of the applicant only, unless further approval is 
obtained from the NHLS.  In the event of this, the applicant shall give due credit, 
including affiliation, of the participation of the NHLS in any such publications or 
presentations. 
 The applicant undertakes to provide the Executive Manager: Academic Affairs, 
Research and Quality Assurance at the NHLS with a copy of any report, presentation 
or publication emanating from the use of this data. 
ACCEPTANCE OF CONDITIONS 
By signing this document we accept the conditions stated above.  
Applicant Signature 
 
 
Date 27/10/2015 
Supervisor Signature  Date   /  /20 
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All fields in this section must be completed 
DATA REQUEST DETAILS 
Request Type 
(Tick) 
 New 
 
Modify 
Data 
Format 
(Tick) 
 Excel 
 CSV 
Data Delivery 
(Tick) 
 CD / DVD 
 Email 
Frequency of 
Extract (Tick) 
 Once 
 
Repeat 
If Repeat, 
specify 
frequency 
 Daily   Monthly 
 Weekly   Annually 
DESCRIPTION OF REQUIRED DATA EXTRACT 
Data required 
Bacteria isolated and DST patterns (on urine sent for MC&S) for 
the given list of paediatric patients (see attached) with Congenital 
Abnormalities of the Urinary Tract (CAKUT) 
 
Region  
(for data extract, e.g. 
Province or Laboratory 
CMJAH 
Date range of extract 
 
1
st
 January 2005 – 31st December 2014 
 
 
Fields required  
(e.g. Patient name,  
Date of Birth, etc) 
Please see attached patient list: 
 Hospital ID (GT number); Organism Isolated; Date of Isolation; 
Resistance Profile for each organism 
ADDITIONAL INFORMATION 
Congenital anomalies of the kidney and urinary tract (CAKUT) are a well-documented risk 
factor for development of UTI in children. 
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There is a paucity of literature on CAKUT and its relation to UTI in South Africa. 
 
In addition to our other study objectives (see attached protocol), we hope to be able to 
determine the incidence of UTI, the type of causative organisms and the sensitivity 
patterns seen in our study population of children with CAKUT. 
 
DESCRIPTION OF INTENDED USE OF DATA EXTRACT  
(e.g. research, epidemiology study, cost analysis of service, drug effectiveness, disease 
surveillance) 
The data will be used as part of Dr Okoronkwo’s research towards her MSC dissertation. 
 
We also hope to have the research published in a reputable scientific journal and presented at a 
relevant forum. 
LIST WHO WILL HAVE ACCESS TO THIS DATA 
Dr Nneka Chioma Okoronkwo; Dr Cecil Levy  
 
 
PROJECT NAME AND REGISTRATION NUMBER  
(if data is required for a registered research project.  Please attach the Ethics Approval.) 
 
Project Name: Urinary tract infection in children with congenital anomalies of the kidney and 
urinary tract attending the Division of Paediatric Nephrology at Charlotte Maxeke 
Johannesburg Academic Hospital, South Africa. 
Protocol reference number: M150709 
Please see the attached confirmation of study approval from the HREC (Medical) of the 
University of the Witwatersrand: Protocol reference number M150709 
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NHLS RESPONSIBILITIES 
The NHLS will:  
 Ascertain if it is possible to extract the required data. 
 Register the application and issue a registration number.  
 Only release the requested data to the applicant whose name is specified on this 
application form. 
After this application has been completed and approved, please raise a service request 
with the NHLS IT Service Desk (Contact Number:  (011) 386-6125/6/7/9): 
 Send an email to helpdesk1@nhls.ac.za, and cc the CDW Manager 
(sue.candy@nhls.ac.za) 
 Scan this application form and attach it to the email, or fax it to (011) 386-6308. 
 
FOR OFFICE USE 
APPROVAL BY BUSINESS  
(Approval will be obtained by the CDW Manager) 
INFORMATION MANAGEMENT UNIT APPROVAL (required for external requests 
and patient identifying data) 
Check list for external 
applicants 
 Signed by Supervisor 
 Ethics Approval attached, if applicable 
Executive  Manager: 
Academic Affairs, 
Research and Quality 
Assurance 
      Signature       Date   /  /20   
CEO APPROVAL (required for sensitive data requests) 
Chief Executive 
Officer 
      
 
 
Signature       Date   /  /20   
APPROVAL BY IT 
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CDW Manager 
      
 
 
Signature       Date   /  /20   
REQUEST TRACKING 
Service Request 
Number 
 
      
 
 
Request Commence 
Date 
 
  /  /20   
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